Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ABOS	Acumen Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$121.33M	n/a	-172.3%	n/a	-$2.00
ABPO	Abpro Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$2.89M	n/a	n/a	n/a	-$1.30
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
ADMA	ADMA Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$510.17M	$146.93M	28.8%	30.8%	19.6%	$0.60
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
AGTX	Agentix Corp. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$485.6K	n/a	n/a	n/a	-$0.01
AIM	AIM ImmunoTech Inc. Manufacturing · Year ended 2025-12-31 · USD	$88.0K	-$13.96M	n/m	n/a	-48.2%	-$8.62
ALEC	Alector, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.05M	-$142.93M	-679.2%	-466.3%	-79.1%	-$1.39
ALGS	Aligos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.19M	-$24.19M	n/m	-45.2%	-39.5%	-$2.45
ALLO	Allogene Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$190.89M	n/a	-65.3%	-100.0%	-$0.87
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
APTN	Adaptin Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.17M	n/a	n/a	n/a	-$0.66
ARMP	Armata Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$173.80M	n/a	n/a	n/a	-$4.80
ARTV	Artiva Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$83.86M	n/a	-76.3%	-100.0%	-$3.43
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
AURA	Aura Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$106.19M	n/a	-77.6%	n/a	-$1.76
AUTL	Autolus Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$75.39M	-$287.53M	-381.4%	-161.4%	644.9%	-$1.08
AVXL	Anavex Life Sciences Corp. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$46.38M	n/a	-48.9%	n/a	-$0.54
BCAB	BioAtla, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.61M	n/a	-164.7%	n/a	-$1.01
BCDA	BioCardia, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$8.23M	n/a	-919.3%	-100.0%	n/a
BCLI	Brainstorm Cell Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.31M	n/a	n/a	n/a	-$1.11
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
BDTX	Black Diamond Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.00M	$22.37M	32.0%	19.9%	n/a	$0.39

Rows per page: 2550 100